Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathy

Source link : https://www.yourblogdomain.com/2024/11/18/novel-crispr-cas9-based-promising-in-attr-cardiomyopathy/

Source link : https://www.newshealth.biz/health-news/novel-crispr-cas9-based-promising-in-attr-cardiomyopathy/ CHICAGO – A CRISPR-Cas9-based investigational therapy was linked with a drop in serum transthyretin (TTR) levels in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), according to phase I data. A single IV infusion of nexiguran ziclumeran (nex-z), a therapy that targets production of TTR in the liver, was delivered to patients […]

Author : yourblogdomain

Publish date : 2024-11-18 01:59:57

Copyright for syndicated content belongs to the linked Source.